医学部附属病院

研究キーワード

乳癌 Breast cancer

研究分野

ライフサイエンス / 腫瘍診断、治療学 /

学歴

-

1988年3月

千葉大学医学部

論文

<2 345 6 >

Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).

Manabu Futamura Mari Oba Norikazu Masuda Hiroko Bando Morihito Okada Yutaka Yamamoto Takanori Kin Toshiaki Saeki Takeshi Nagashima Takashi Kuwayama Uhi Toh Akira Hirano Masafumi Inokuchi Kazuhiko Yamagami Yutaka Mizuno Yasuyuki Kojima Takahiro Nakayama Hiroyuki Yasojima Shinji Ohno

Breast cancer (Tokyo, Japan) 2021年4月

BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-PTX), a novel taxane formulation, was developed to avoid cremophor/ethanol-associated toxicities including peripheral neuropathy and hypersensitivity. At least 35 phase II studies using combin...

RVSによる治療前後のCEUS画像のfusion

榊原淳太山田英幸山本寛人高田護藤本浩司長嶋健大塚将之

乳腺甲状腺超音波医学 10(2) 176-176 2021年4月

RVSによる治療前後のCEUS画像のfusion

榊原淳太山田英幸山本寛人高田護藤本浩司長嶋健大塚将之

乳腺甲状腺超音波医学 10(2) 176-176 2021年4月

Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).

Toshinari Yamashita Hidetoshi Kawaguchi Norikazu Masuda Masahiro Kitada Kazutaka Narui Masaya Hattori Tetsuhiro Yoshinami Nobuki Matsunami Kazuhiro Yanagihara Teru Kawasoe Takeshi Nagashima Hiroko Bando Hiroshi Yano Yoshie Hasegawa Rikiya Nakamura Masahiro Kashiwaba Satoshi Morita Shinji Ohno Masakazu Toi

Investigational new drugs 39(1) 217-225 2021年2月

Purpose To date, it is not clear which anticancer agent is useful in combination with trastuzumab and pertuzumab As the first and second selective regimens for advanced or metastatic breast cancer (AMBC), this multicenter, open-label, phase II tri...

Genomic profiling of multiple tissues in two patients with multiple endocrine neoplasia type 1.

Akane Naruoka Sumiko Ohnami Takeshi Nagashima Masakuni Serizawa Keiichi Hatakeyama Keiichi Ohshima Shumpei Ohnami Kenichi Urakami Yasue Horiuchi Yoshimi Kiyozumi Hiroyuki Matsubayashi Masato Abe Takuma Ohishi Toru Kameya Takashi Sugino Tetsuro Onitsuka Mitsuhiro Isaka Yasuhisa Ohde Teiichi Sugiura Takaaki Ito Katsuhiko Uesaka Yasuto Akiyama Masatoshi Kusuhara Ken Yamaguchi

Biomedical research (Tokyo, Japan) 42(2) 89-94 2021年

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant tumor syndrome. This hereditary cancer is caused by germline variants in MEN1. Two patients with MEN1 were identified via whole exome sequencing and gene expression profile analys...